Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

miRNAs are stable in colorectal cancer archival tissue blocks.

Bovell L, Shanmugam C, Katkoori VR, Zhang B, Vogtmann E, Grizzle WE, Manne U.

Front Biosci (Elite Ed). 2012 Jan 1;4:1937-40.

2.

MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.

Boisen MK, Dehlendorff C, Linnemann D, Schultz NA, Jensen BV, Høgdall EV, Johansen JS.

BMC Cancer. 2015 Dec 29;15:1024. doi: 10.1186/s12885-015-2030-2.

3.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
4.

Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.

Peskoe SB, Barber JR, Zheng Q, Meeker AK, De Marzo AM, Platz EA, Lupold SE.

BMC Cancer. 2017 Jan 6;17(1):32. doi: 10.1186/s12885-016-3008-4.

5.

Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.

Ghanbari R, Rezasoltani S, Hashemi J, Mohamadkhani A, Tahmasebifar A, Arefian E, Mobarra N, Asadi J, Nazemalhosseini Mojarad E, Yazdani Y, Knuutila S, Malekzadeh R.

Arch Iran Med. 2017 Feb;20(2):92-95. doi: 0172002/AIM.006.

6.

Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.

Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z.

Oncotarget. 2015 Nov 10;6(35):37544-56. doi: 10.18632/oncotarget.6065.

7.

The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.

Bovell LC, Shanmugam C, Putcha BD, Katkoori VR, Zhang B, Bae S, Singh KP, Grizzle WE, Manne U.

Clin Cancer Res. 2013 Jul 15;19(14):3955-65. doi: 10.1158/1078-0432.CCR-12-3302. Epub 2013 May 29.

8.

MiR-106a is an independent prognostic marker in patients with glioblastoma.

Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.

Neuro Oncol. 2013 Jun;15(6):707-17. doi: 10.1093/neuonc/not001. Epub 2013 Feb 14.

9.

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples.

Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J.

RNA. 2007 Oct;13(10):1668-74. Epub 2007 Aug 13.

10.

The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.

Xu L, Li M, Wang M, Yan D, Feng G, An G.

BMC Cancer. 2014 Sep 25;14:714. doi: 10.1186/1471-2407-14-714.

11.
12.

Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.

Zhu M, Zhang N, He S.

Pathol Res Pract. 2014 Dec;210(12):909-15. doi: 10.1016/j.prp.2014.07.008. Epub 2014 Jul 30.

PMID:
25115709
13.

[DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].

Li L, Zhang ZM, Liu Y, Wei MH, Xue LY, Zou SM, Di XB, Han NJ, Zhang KT, Xu ZG, Gao YN.

Zhonghua Bing Li Xue Za Zhi. 2010 Jun;39(6):391-5. Chinese.

PMID:
21055156
14.

miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue.

Leite KR, Canavez JM, Reis ST, Tomiyama AH, Piantino CB, Sañudo A, Camara-Lopes LH, Srougi M.

Urol Oncol. 2011 Sep-Oct;29(5):533-7. doi: 10.1016/j.urolonc.2009.05.008. Epub 2009 Sep 6.

PMID:
19734068
15.

MicroRNA-223 functions as an oncogene in human colorectal cancer cells.

Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y, Lu Y.

Oncol Rep. 2014 Jul;32(1):115-20. doi: 10.3892/or.2014.3173. Epub 2014 May 8.

PMID:
24819398
16.

Intra-tumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer.

Jepsen RK, Novotny GW, Klarskov LL, Christensen IJ, Riis LB, Høgdall E.

Exp Mol Pathol. 2016 Feb;100(1):125-31. doi: 10.1016/j.yexmp.2015.12.004. Epub 2015 Dec 8.

PMID:
26681654
17.

Variability in microRNA recovery from plasma: Comparison of five commercial kits.

Brunet-Vega A, Pericay C, Quílez ME, Ramírez-Lázaro MJ, Calvet X, Lario S.

Anal Biochem. 2015 Nov 1;488:28-35. doi: 10.1016/j.ab.2015.07.018. Epub 2015 Aug 10.

PMID:
26271186
18.

MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.

Ak S, Tunca B, Tezcan G, Cecener G, Egeli U, Yilmazlar T, Ozturk E, Yerci O.

J Surg Res. 2014 Sep;191(1):113-22. doi: 10.1016/j.jss.2014.03.057. Epub 2014 Mar 24.

PMID:
24746948
19.

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.

Int J Oncol. 2009 Apr;34(4):1069-75.

PMID:
19287964
20.

Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Zhang P, Ji DB, Han HB, Shi YF, Du CZ, Gu J.

World J Gastroenterol. 2014 Sep 14;20(34):12241-8. doi: 10.3748/wjg.v20.i34.12241.

Supplemental Content

Support Center